Hello!
To view this content, please sign up or log in – it’s free and easy! Stay ahead with curated regulatory insights designed for professionals like you.
"On January 17, 2025, the Department of Health and Human Services (HHS) issued an update regarding "HHS Provides $590 Million to Accelerate Pandemic Influenza mRNA-based Vaccine Development, Enhance Platform Capability for Other Emerging Infectious Disease". The award will enhance pandemic preparedness by leveraging flexible platforms, with HHS providing approximately $590 million to Moderna. This funding allows Moderna to accelerate development of an H5N1 mRNA influenza vaccine and expand the clinical data supporting mRNA vaccines."
Hello!
To view this content, please sign up or log in – it’s free and easy! Stay ahead with curated regulatory insights designed for professionals like you.
Highlights content goes here...
Hello!
To view this content, please sign up or log in – it’s free and easy! Stay ahead with curated regulatory insights designed for professionals like you.
An OTP has been sent to your registered email address.